account_id none on file
legal_name Spyre Therapeutics, Inc.
ticker SYRE
cik 1636282
domain spyre.com
linkedin_company_url https://www.linkedin.com/company/spyre-therapeutics/
entry_point_account_id none on file
name Spyre Therapeutics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 7 executives 6 family 0
why_nownone on file
callsnone on file
filings
In addition, the increased costs may require us to reduce costs in other areas of our business or increase the prices of our product candidates, once commercialized.
filing / Aug 4, 2026 / receipt
We may be forced to reduce our operating expenses and raise additional funds to meet our working capital needs, principally through the additional sales of our securities or debt financings or entering into strategic collaborations.
filing / Aug 4, 2026 / receipt
In addition, the increased costs may require us to reduce costs in other areas of our business or increase the prices of our product candidates, once commercialized.
filing / May 5, 2026 / receipt
We may be forced to reduce our operating expenses and raise additional funds to meet our working capital needs, principally through the additional sales of our securities or debt financings or entering into strategic collaborations.
filing / May 5, 2026 / receipt
Vice President, Clinical Development | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5365798008", "remote": true, "category": "other", "function": "executive", "location": "US- Remote"
company_statement / Jul 21, 2026 / receipt
Senior Medical Director, Clinical Development | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5350060008", "remote": true, "category": "other", "function": "clinical", "location": "US-
company_statement / Jul 15, 2026 / receipt
Senior Director, Biostatistics | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5282836008", "remote": true, "category": "other", "function": "other", "location": "US- Remote", "job_tit
company_statement / Jul 3, 2026 / receipt
executives
| Cameron Turtle | Chief Executive Officer | - | receipt |
| Jeffrey M. Goldberg | President and Chief Executive Officer | - | receipt |
| Jonathan Alspaugh | President | - | receipt |
| Leslie Sloan | Chief Operating Officer | - | receipt |
| Scott Burrows | Chief Financial Officer | receipt | |
| Steven Weber | Vice President | - | receipt |
familynone on file
upcoming
| 2026-11-03 | earnings call | scheduled | ir |
changes
| 2023-11-28 | Chief Executive Officer, appointed | sec_8k |
| 2023-09-05 | Chief Financial Officer, appointed | sec_8k |
| 2023-05-19 | President, appointed | sec_8k |
| 2022-11-30 | Interim Chief Executive Officer, departed | sec_8k |
| 2022-11-30 | President and Chief Executive Officer, appointed | sec_8k |
| 2022-03-18 | Chief Financial Officer, appointed | sec_8k |
| 2021-07-08 | Chief Financial Officer, appointed | sec_8k |
| 2021-02-03 | Vice President, appointed | sec_8k |
| 2019-03-08 | Chief Operating Officer, appointed | sec_8k |
mcp_package_hint
slug spyre-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$